1. Oncolytic virus therapy in cancer: A current review
   Jonathan Santos Apolonio et al, 2021, World Journal of Virology CrossRef
2. A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
   Ann W. Silk et al, 2023, Cancer Immunology, Immunotherapy CrossRef
3. The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
   Luyao Wang et al, 2022, Frontiers in Oncology CrossRef
4. Trial Watch—Oncolytic viruses and cancer therapy
   Jonathan Pol et al, 2016, OncoImmunology CrossRef
5. Oncolytic immunotherapy: The new clinical outbreak
   Jean-François Fonteneau et al, 2016, OncoImmunology CrossRef
6. Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration
   Zinnia P. Parra-Guillen et al, 2021, Frontiers in Pharmacology CrossRef
7. Oncolytic virus preclinical toxicology studies
   Agnija Rasa et al, 2023, Journal of Applied Toxicology CrossRef
8. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
   Yi-Ying Wu et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
9. A physiologically based pharmacokinetic model for V937 oncolytic virus in mice
   Sara Peribañez-Dominguez et al, 2023, Frontiers in Pharmacology CrossRef
10. The Effects of Mesenchymal Stem Cells Loaded with Oncolytic Coxsackievirus A21 on Mouse Models of Colorectal Cancer
    Reza Karbalaee et al, 2024, Current Cancer Drug Targets CrossRef